Takeshi Masuda Selected Research

Takeshi Masuda Research Topics

Disease

34	Neoplasms (Cancer) 07/2022 - 11/2013
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 06/2011
16	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2018
14	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022 - 01/2018
8	Adenocarcinoma of Lung 01/2022 - 06/2011
8	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2011
7	Disease Progression 07/2022 - 12/2018
7	Carcinoma (Carcinomatosis) 05/2021 - 01/2011
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
6	Fibrosis (Cirrhosis) 01/2021 - 01/2017
5	Lung Injury 12/2021 - 01/2017
5	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2016
4	Asthma (Bronchial Asthma) 12/2022 - 01/2017
4	Bronchiectasis 02/2021 - 01/2018
4	Inflammation (Inflammations) 01/2021 - 09/2005
4	Human Influenza (Influenza) 06/2009 - 08/2002
3	Pneumonia (Pneumonitis) 10/2022 - 01/2018
3	Adenocarcinoma 01/2022 - 10/2014
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 10/2017
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2013
3	Lewis Lung Carcinoma 09/2018 - 11/2013
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2017 - 01/2011
3	Developmental Dysplasia of the Hip 08/2013 - 06/2012
2	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2017
2	Carcinogenesis 01/2022 - 10/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2014
2	Stroke (Strokes) 09/2021 - 12/2016
2	Emphysema 04/2021 - 01/2018
2	Thrombosis (Thrombus) 02/2021 - 03/2013
2	Venous Thromboembolism 02/2021 - 03/2019
2	Hemolysis 02/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 09/2018
2	Diabetes Mellitus 01/2021 - 07/2019
2	Acute Lung Injury 10/2020 - 01/2020
2	Intracranial Embolism 01/2020 - 03/2019
2	Infections 12/2019 - 09/2005
2	Testicular Neoplasms (Testicular Cancer) 12/2019 - 03/2013
2	Leukemia 12/2018 - 04/2015
2	Malignant Mesothelioma 01/2018 - 01/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2016 - 01/2007
2	Osteoarthritis 08/2013 - 06/2012
2	Hemorrhage 12/2012 - 04/2005
2	Pain (Aches) 09/2011 - 04/2005

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2008
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2014
9	LigandsIBA 07/2022 - 01/2016
6	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 03/2013
6	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 03/2013
5	pembrolizumabIBA 01/2022 - 03/2019
5	Pharmaceutical PreparationsIBA 02/2021 - 07/2003
5	Plasminogen Activator Inhibitor 1IBA 01/2019 - 11/2013
5	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 11/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2011
4	AntigensIBA 04/2021 - 01/2019
4	CytokinesIBA 01/2021 - 01/2017
4	AntibodiesIBA 12/2019 - 12/2018
4	Zanamivir (Relenza)FDA Link 06/2009 - 08/2002
3	SteroidsIBA 12/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 12/2021 - 09/2019
3	HMGB1 Protein (HMG1)IBA 12/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2015
3	NivolumabIBA 01/2020 - 01/2018
3	EnzymesIBA 12/2019 - 03/2016
3	SK-216IBA 01/2016 - 11/2013
3	Membrane Proteins (Integral Membrane Proteins)IBA 06/2014 - 02/2008
2	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 12/2022 - 04/2022
2	B7-H1 AntigenIBA 02/2022 - 12/2019
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 03/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021 - 06/2011
2	Gefitinib (Iressa)FDA Link 10/2021 - 06/2011
2	RNA Precursors (Precursor, mRNA)IBA 09/2021 - 12/2018
2	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 09/2005
2	PlatinumIBA 01/2021 - 01/2020
2	Gemcitabine FDA Link 01/2021 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2017
2	Heparin (Liquaemin)FDA LinkGeneric 03/2019 - 01/2007
2	AnticoagulantsIBA 03/2019 - 03/2013
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 03/2016
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 12/2018
2	suplatast tosilateIBA 01/2019 - 01/2017
2	ChemokinesIBA 01/2019 - 01/2017
2	Pemetrexed (MTA)FDA Link 12/2018 - 09/2018
2	Bevacizumab (Avastin)FDA Link 12/2018 - 09/2018
2	PowdersIBA 09/2018 - 12/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 11/2013
2	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018 - 07/2015

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 07/2022 - 01/2011
18	Therapeutics 01/2022 - 09/2005
5	Chemoradiotherapy 12/2021 - 10/2017
5	Radiotherapy 12/2021 - 06/2017
5	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2017 - 09/2011
4	Traction 02/2021 - 01/2018
3	Cystectomy 05/2021 - 01/2011
3	Catheters 01/2020 - 12/2012
2	Oral Administration 10/2022 - 06/2017
2	Nephroureterectomy 05/2021 - 06/2013